CN212880589U

CN212880589U - Rehabilitation device after rectal cancer operation

Info

Publication number: CN212880589U
Application number: CN202020607499.3U
Authority: CN
Inventors: 许建多
Original assignee: Individual
Current assignee: Individual
Priority date: 2020-04-21
Filing date: 2020-04-21
Publication date: 2021-04-06
Anticipated expiration: 2030-04-21

Abstract

The utility model discloses a device is strong after carcinoma of rectum operation relates to the medical equipment field. The device comprises a treatment end, wherein the treatment end comprises a concentrated drug delivery pipe in the middle, a divergent drug delivery pipe sleeved on the concentrated drug delivery pipe and an inflatable balloon of which the outermost layer wraps the divergent drug delivery pipe; wherein, concentrate for the body structure that the pencil set up for the straight line, disperse for the pencil including the cover establish concentrate for the pencil on the pencil with straight line pipe, and with straight line pipe intercommunication use its outer wall as the starting point to a plurality of that disperses all around the tubule, the other end of dispersing the tubule is connected and is aerifyd the sacculus, and its port with aerify sacculus surface parallel and level and external intercommunication. The delivery pipe comprises three delivery cavities which are respectively communicated with the concentrated administration pipe, the divergent administration pipe and the inflatable balloon. The administration end comprises three administration heads respectively communicated with the three transmission cavities. The device can quickly and effectively prevent and treat diseases such as anastomotic stenosis, ulcer, intestinal inflammation and the like after operations of patients with ultralow rectal cancer.

Description

Rehabilitation device after rectal cancer operation

Technical Field

The utility model relates to the field of medical equipment, especially, relate to a device is strong after carcinoma of rectum operation.

Background

At present, the condition of gradually narrowing of an intestinal cavity, ulcer of an anastomotic stoma, inflammatory reaction of the intestinal cavity and the like caused by scar proliferation of the anastomotic stoma appears in many patients with ultralow rectal cancer after operation. At present, the treatment measures aiming at the related complications are as follows: 1. the treatment for the narrow anastomotic stoma comprises the traditional hard instrument expansion and the sequential multiple expansion of fingers; 2. the conditions that an anastomotic stoma and a nearby intestinal canal are polluted by intestinal flora, scars heal, local blood circulation is poor, and ulcer and intestinal inflammatory lesion occur are treated by adopting disposable administration or oral medicaments.

In the above manner, because the diameter of the dilating instrument and the diameter of the operator's finger cannot be adjusted, there are risks related to poor subjective feeling of the patient and easy occurrence of bleeding, tearing, even perforation, etc. The long-term efficacy of the drug cannot be ensured by one-time administration, and the symptoms of patients cannot be relieved in time by long period of taking the drug orally

SUMMERY OF THE UTILITY MODEL

The utility model aims to solve the technical problem that a rectal cancer postoperative rehabilitation device is provided for effectively preventing and treating diseases such as narrow anastomotic stoma, ulcer and intestinal inflammation appearing after the operation of an ultra-low rectal cancer patient.

In order to solve the technical problem, the utility model discloses the technical scheme who takes is:

a post-operative rehabilitation device for rectal cancer, comprising:

the treatment end comprises a centralized dosing tube in the middle, a divergent dosing tube sleeved on the centralized dosing tube and an inflatable balloon of which the outermost layer wraps the divergent dosing tube; the concentrated dosing tube is of a tube body structure arranged linearly, the dispersing dosing tube comprises a linear tube sleeved on the concentrated dosing tube and a plurality of dispersing small tubes which are communicated with the linear tube and disperse around the linear tube by taking the outer wall of the dispersing small tubes as a starting point, the other ends of the dispersing small tubes are connected with the inflatable balloon, and the ports of the dispersing small tubes are communicated with the surface of the inflatable balloon in a parallel and level mode with the outside.

The delivery pipe comprises three delivery cavities which are respectively communicated with the concentrated administration pipe, the divergent administration pipe and the inflatable balloon.

The drug delivery end comprises three drug delivery heads which are respectively communicated with the three transmission cavities.

The further technical proposal is that the administration heads are fixed with a control knob and an expansion valve.

The further technical proposal is that the divergent small tubes are evenly distributed on the outer wall of the straight tube.

A further technical scheme lies in that the utility model wholly adopts the colloid material.

The further technical proposal is that the inflatable balloon is a balloon cavity colloid with smooth outside.

The further technical proposal is that the hardness of the divergence administration tube is higher than that of the inflatable balloon.

The further technical proposal is that the outer surface of the inflatable saccule is fixed with scale marks along the length direction of the direct administration tube.

Adopt the produced beneficial effect of above-mentioned technical scheme to lie in:

the device is soft colloid, can expand gradually to coincide mouthful stenosis, and can freely regulate and control its diameter, and is safe in utilization, makes the subjective experience of patient more comfortable.

The concentrated administration tube of the device can achieve two effects of administration and enema, the divergent administration tube can achieve continuous or disposable administration on peripheral anastomotic ulcer or inflammatory infection, and the liquid medicine is uniformly coated on the ulcer to enhance the administration effect.

Moreover, the inflatable balloon plays a role in dilating an anastomotic stoma, and can adjust the diameter of the inflatable balloon to assist the concentrated administration tube and the divergent administration tube to administer the medicine.

The divergent tubules can ensure that the liquid medicine is uniformly distributed around the ulcer, and can also play a role in supporting the inflatable balloon, thereby ensuring the effectiveness of anastomotic stoma expansion.

In addition, the device is integrated and multi-purpose, can improve the symptom of dry stool and realize continuous intestinal administration, can be used as a safety device for postoperative enema and administration, and solves most problems after intestinal operations.

Drawings

The present invention will be described in further detail with reference to the accompanying drawings and specific embodiments.

Fig. 1 is a schematic structural diagram of the present invention;

fig. 2 is a schematic sectional structure view of the treatment end of the present invention.

Detailed description of the preferred embodiments

The technical solutions in the embodiments of the present invention are clearly and completely described below with reference to the drawings in the embodiments of the present invention, and it is obvious that the described embodiments are some, not all, embodiments of the present invention. Based on the embodiments only in the present invention, all other embodiments obtained by those skilled in the art without creative efforts belong to the protection scope of the present invention.

In the following description, numerous specific details are set forth in order to provide a thorough understanding of the present invention, but the present invention may be implemented in other ways different from the specific details set forth herein, and one skilled in the art may similarly generalize the present invention without departing from the spirit of the present invention, and therefore the present invention is not limited to the specific embodiments disclosed below.

As shown in fig. 1-2, a rehabilitation device after rectal cancer surgery comprises a treatment end 1, a transmission tube 2 and a drug administration end; the treatment end 1 comprises a centralized administration tube 11 in the middle, a divergent administration tube sleeved on the centralized administration tube 11 and an inflatable balloon 13 of which the outermost layer wraps the divergent administration tube; the concentrated administration tube 11 is a tube body structure arranged linearly, the divergent administration tube comprises a linear tube 121 sleeved on the concentrated administration tube 11 and a plurality of divergent small tubes 122 communicated with the linear tube 121 and divergent to the periphery from the outer wall of the linear tube as a starting point, the other ends of the divergent small tubes 122 are connected with the inflatable balloon 13, and the ports of the divergent small tubes are communicated with the outside along the surface of the inflatable balloon 13. The transmission tube 2 comprises three transmission cavities which are respectively communicated with a concentrated administration tube 11, a divergent administration tube and an inflatable balloon 13. The administration end comprises three administration heads 3 respectively communicated with the three transmission cavities.

In an uninflated state, the inflatable balloon 13 is attached to the base plate of the linear tube 121 and gradually expands to form a fusiform ball shape in the inflating process. In the use process of the device, gas and liquid are injected into the device from the three dosing heads 3 respectively to check the unobstructed and sealed conditions. After rectal digital examination is carried out, lubricating liquid is smeared on the outer wall of the treatment end 1 under the condition that no contraindication exists, the treatment end 1 is slowly placed into the anus of a patient under the condition that no gas is filled, the placement depth is determined according to the digital examination depth, the specific size is observed according to the scale mark 131, and then different medicine feeding heads 3 can be selected according to treatment requirements and filled with gas or treatment liquid according to the treatment requirements.

If the anastomotic stenosis is the case, the inflation quantity of the administration head 3 connected with the inflatable saccule 13 is determined according to the stricture degree of the anastomotic stenosis of the patient, at the moment, the diameter of the exposed part of the inflatable saccule 13 can be measured to determine the actual work doing diameter of the internal inflation, the inflation is carried out from less to more, the slow inflation is carried out after adaptation, the treatment time is maintained for 0.5 to 1 hour alternately by combining finger-examination inflation and deflation within the tolerance range, the treatment end 1 is slowly withdrawn after deflation, the presence or absence of blood stains and necrotic tissues in the treatment end 1 is checked, and the treatment effect is judged by finger-examination. The treatment device is then thoroughly rinsed and sterilized for single use by a single person to avoid cross-contamination.

If the treatment item is the situation without anastomotic stenosis, which is the situation of anastomotic ulcer or inflammatory infection, continuous administration is needed, the administration head 3 connected with the inflatable balloon 13 is inflated firstly, the inflation quantity of the inflatable balloon 13 is adjusted, the anastomosis intestinal wall is attached to the intestinal wall of the anastomotic stoma with proper tightness, then the administration head 3 connected with the centralized administration tube 11 or the divergent administration tube is connected, and trace amount of medicine is pumped continuously or the medicine is administered rapidly. When the divergent administration tube is used, the balloon 13 is inflated under pressure to a diameter of the intestinal tract near the anastomosis, and then the surface of the balloon is brought into close contact with the ulcer surface, followed by administration, which is continuous administration. Or can be sprayed on the ulcer surface by early pressurization without completely adhering to the intestinal wall or anastomotic stoma, which is timed and intermittent administration. When the centralized administration tube 11 is used, the liquid medicine is extruded from the other end, and the treatment end 1 is moved backward according to the administration requirement for continuous administration.

If the treatment item is constipation, the slow or fast enema is administered by using the concentrative administration tube 11 or the divergent administration tube according to the constipation condition and the anastomotic stoma condition of the patient. Moreover, the administration head 3 is fixed with a control knob 30 and a contracting valve, and can be precisely adjusted.

Wherein, the divergent canaliculi 122 are evenly distributed on the outer wall of the linear tube 121, namely, can be evenly distributed at the ulcer part, thereby achieving the effect of even smearing when in administration.

The device is wholly made of colloid materials. The inflatable balloon 13 is a gel with a smooth outer cavity. The hardness of the divergent administration tube is higher than the hardness of the inflatable balloon 13. To facilitate support of the inflatable balloon 13.

The above is only the preferred embodiment of the present invention, and any person can make some simple modifications, deformations and equivalent replacements according to the present invention, all fall into the protection scope of the present invention.

Claims

1. A post-operative rehabilitation device for rectal cancer, comprising:

the treatment end (1) comprises a centralized administration tube (11) in the middle, a divergent administration tube sleeved on the centralized administration tube (11) and an inflatable balloon (13) of which the outermost layer wraps the divergent administration tube; the concentrated administration tube (11) is of a tube body structure which is linearly arranged, the divergent administration tube comprises a straight tube (121) which is sleeved on the concentrated administration tube (11) and a plurality of divergent small tubes (122) which are communicated with the straight tube (121) and diverge from the outer wall of the straight tube to the periphery, the other ends of the divergent small tubes (122) are connected with the inflatable balloon (13), and the ports of the divergent small tubes are flush with the surface of the inflatable balloon (13) and communicated with the outside;

the delivery tube (2) comprises three delivery cavities which are respectively communicated with the concentrated administration tube (11), the divergent administration tube and the inflatable balloon (13);

a dosing end comprising three dosing heads (3) communicating with the three transfer lumens, respectively.

2. A postoperative rehabilitation device for rectal cancer according to claim 1, characterized in that the administration head (3) is fixed with a control knob (30) and a contracting valve.

3. A device according to claim 1, characterized in that said divergent canaliculi (122) are uniformly distributed on the outer wall of said rectilinear canal (121).

4. The device of claim 1, wherein the whole body of the device is made of gel.

5. A postoperative rehabilitation device for rectal cancer according to claim 4, characterized in that the inflatable balloon (13) is an external smooth lumen gel.

6. A postoperative rehabilitation device for rectal cancer according to claim 5, characterized in that the hardness of the divergent drug delivery tube is higher than the hardness of the inflatable balloon (13).

7. A postoperative rehabilitation apparatus for rectal cancer according to claim 1, characterized in that graduation lines (131) are fixed on the outer surface of the inflatable balloon (13) along the length direction of the direct administration tube.